drugset / Trial / NCT00464854

Glucose Control With Multiple Daily Insulin Injections In Diabetic Patients Hospitalized In A General Medicine Ward

NCT00464854

Terminated 100 enrolled Assaf-Harofeh Medical Center
Non-randomizedSingle-groupOpen-labelTreatment

Summary

At least 20% of patients hospitalized in the general medical and surgical wards at any given time suffer from diabetes. It has been demonstrated that poor clinical outcome correlates with the degree of hyperglycemia in these patients. Strict glucose control in hospitalized patients improves clinical outcomes in the setting of acute myocardial infarction, cardiac surgical procedures, infection and critical illness in patients hospitalized in intensive care units if insulin is applied intravenously. It is, however, complex to obtain strict glucose control in the general surgical and medical wards. These wards are usually understaffed as compared to intensive care units and therefore are incapable to perform the necessary close monitoring essential in patients treated with intravenous insulin. We intend to test the feasibility of glucose control by multiple daily subcutaneous injections with long acting basal glargine insulin and pre-meal insulin analogues. If good glucose control can be achieved, this would be a valid, more convenient and acceptable alternative to intravenous insulin infusions to obtain good glucose control in diabetic patients hospitalized in general internal medicine wards.

Timeline

Start
2005-07
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin aspart Protein / enzyme biologic Subcutaneous
Subject insulin glargine Protein / enzyme biologic 0.3 iu/kg Subcutaneous
Subject insulin glargine Protein / enzyme biologic 0.8 iu/kg Subcutaneous
Subject insulin glargine Protein / enzyme biologic Subcutaneous

Indications